GlassScriptPhysician profile
Brittany J Cox
NPI 1134620206
$3,186.94
in general payments reported to CMS, 2019-2025
17 companies · $573 in 2025
The $573 reported for 2025 was more than what 77% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $12.90 · 2022: $124 · 2023: $1,409 · 2024: $1,068 · 2025: $573.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,050.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $700.10 | 2022-2025 | |
| Organogenesis INC. | $550.27 | 2023-2024 | Puraply |
| E.R. Squibb & Sons, L.L.C. | $334.80 | 2022-2024 | Camzyos, Eliquis |
| Pfizer INC. | $310.64 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $248.59 | 2023-2025 | Farxiga, Brilinta, Wainua |
| Janssen Pharmaceuticals, INC | $191.98 | 2022-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $176.82 | 2022-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $145.41 | 2024-2025 | Assure Wcd |
| Abbott Laboratories | $130.71 | 2025 | Proclaim |
| Merck Sharp & Dohme LLC | $116.29 | 2022-2024 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.84 | 2023-2025 | Jardiance |
| Lexicon Pharmaceuticals, INC. | $52.18 | 2024 | |
| Philips North America LLC | $38.63 | 2023-2024 | (Ck4) Mcot |
| Medtronic, INC. | $30.91 | 2024-2025 | Cobalt Dr Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Genzyme Corporation | $23.86 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $15.01 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ironshore Pharmaceuticals INC. | $12.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brittany Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.